Baystate Wealth Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Baystate Wealth Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-741	Closed	-$70K	–	746
2017 Q4	$70K	Hold	741	–	–	0.01%	169
2017 Q3	$44K	Hold	741	–	–	0.01%	197
2017 Q2	$45K	Buy	+741	New	+$42.2K	0.01%	187

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Baystate Wealth Management's BIVV Position: Q1 2018 in Review

Baystate Wealth Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 741 shares — an estimated $70K sold.

Baystate Wealth Management first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $70K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Baystate Wealth Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Baystate Wealth Management sold 741 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $70K.
Baystate Wealth Management first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
Baystate Wealth Management's Bioverativ Inc. Common Stock position peaked at $70K in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Baystate Wealth Management's 13F filing for Q1 2018, filed 24 Apr 2018.